- Oncology Drug Approval News Flash: Optune Pax, a low electric field tumor treating fields device, approved with gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer
FDA approval summary On February 11, 2026, the U.S. Food and Drug Administration (FDA) approved a low electric […]
- Series: Untangling Cancer Worries — Your First GuidePart 5: Genetic Variants and Cancer Risk — What Tests Can Tell You (and What They Can’t)
Series: Untangling Cancer Worries — Your First Guide Even without medical knowledge, this series helps you cal […]
- Series: Untangling Cancer Worries — Your First Guide Part 4: Benign vs Malignant Tumors — What the Words Mean (and What to Confirm First)
Series: Untangling Cancer Worries — Your First Guide Even without medical knowledge, this series helps you cal […]
- Series: Untangling Cancer Worries — Your First Guide Part 3: What Does “Metastasis” Mean? How It Differs From Stage—and How Treatment Plans Can Change
Series: Untangling Cancer Worries — Your First Guide Even without medical knowledge, this series helps you cal […]
- Oncology Drug Approval News Flash: Pembrolizumab plus paclitaxel with or without bevacizumab approved for platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal carcinoma
FDA approval summary On February 10, 2026, the U.S. Food and Drug Administration (FDA) approved pembrolizumab […]
- Series: Untangling Cancer Worries — Your First Guide Part 2: If Cancer Crosses Your Mind: 3 Things to Check First (with “When to Seek Care” signs)
Series: Untangling Cancer Worries — Your First Guide Even without medical knowledge, this series helps you cal […]
- Series: Untangling Cancer Worries — Your First Guide Part 1: When You’re Diagnosed With Cancer: What to Do (and Not Do) in the First Week — A Family-Friendly Question List
Series: Untangling Cancer Worries — Your First Guide Even without medical knowledge, this series helps you cal […]
- From Beginner to Expert: AI in Drug Discovery – A Definitive Guide from Lab to Market (Extra Chapter, Snapshot as of November 22, 2025) focuses only on the latest AI-driven case studies and summarizes how far AI has actually progressed in real drug discovery and development.
1. Where Does AI in Drug Discovery Stand in 2025? Between 2024 and 2025, AI in drug discovery has quietly move […]
- From Beginner to Expert: AI in Drug Discovery – A Definitive Guide from Lab to Market (Part 7: “Putting It All Together”) summarizes a cross-modality roadmap for AI in drug discovery and development, clarifies what AI can and cannot realistically do, and outlines strategic considerations from lab bench to market access.
1. Recap: A Cross-Modality “AI in Drug Discovery” Map In Parts 1–6, we walked through: Each time, we looked at […]
- From Beginner to Expert: AI in Drug Discovery – A Definitive Guide from Lab to Market (Part 6: “Cell & Gene Therapy × AI”) maps how AI is used from CAR-T/TCR and vector design to manufacturing and quality control, and clarifies both its potential and its current limitations in these complex modalities.
1. Why “Cell & Gene Therapy × AI” Is Both Difficult and Important In Part 6, we focus on cell therapies (e […]